MTEX: Mannatech, Incorporated Stock

by  •  • Comments Off on MTEX: Mannatech, Incorporated Stock

SIC 2833 – Medicinal Chemicals and Botanical Products

Valuation
Market Cap ($M) 17.87
Enterprise Value ($M) 9.46
Book Value ($M) 8.61
Book Value / Share 4.53
Price / Book 2.07
NCAV ($M) -1.32
NCAV / Share -0.69
Price / NCAV -13.53

Profitability (mra)
Return on Invested Capital (ROIC) 0.16
Return on Assets (ROA) 0.06
Return on Equity (ROE) 0.24

Liquidity (mrq)
Quick Ratio 0.73
Current Ratio 1.25

Balance Sheet (mrq) ($M)
Current Assets 26.12
Assets 36.06
Liabilities 27.44
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 117.87
Operating Income 1.44
Net Income 2.49
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 2.26
Cash from Investing -0.28
Cash from Financing 1.96

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
01-24 13G Lacore Terry 5.30
11-01 13G Robbins Marlin Ray 5.10

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-26 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One)
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One)
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-21 82 638 12.85
2025-04-17 11 217 5.07
2025-04-16 51 625 8.16

(click for more detail)

Similar Companies
MLTX – MoonLake Immunotherapeutics MNPR – Monopar Therapeutics Inc.
MRKR – Marker Therapeutics, Inc. MTVA – MetaVia Inc.
MYNZ – Mainz Biomed N.V.


Financial data and stock pages provided by
Fintel.io